MedTrace Logo

Identifying Factors That Predict Antidepressant Treatment Response

NCT00360399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 344

Last updated 2016-08-30

Study results available
· View outcomes & findings →

Summary

This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.

Conditions

Interventions

DRUG

Escitalopram

Escitalopram 10 to 20 mg per day for 12 weeks

DRUG

Duloxetine

Duloxetine 30 to 60 mg per day for 12 weeks

BEHAVIORAL

Cognitive behavioral therapy (CBT)

CBT will include 16 one-hour sessions provided over 12 weeks.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Helen S. Mayberg, MD · Emory University

  • W. Edward Craighead, PhD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00360399 on ClinicalTrials.gov